Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 28;22(23):12879.
doi: 10.3390/ijms222312879.

Cyclic Nucleotide (cNMP) Analogues: Past, Present and Future

Affiliations
Review

Cyclic Nucleotide (cNMP) Analogues: Past, Present and Future

Erik Maronde. Int J Mol Sci. .

Abstract

Cyclic nucleotides are important second messengers involved in cellular events, and analogues of this type of molecules are promising drug candidates. Some cyclic nucleotide analogues have become standard tools for the investigation of biochemical and physiological signal transduction pathways, such as the Rp-diastereomers of adenosine and guanosine 3',5'-cyclic monophosphorothioate, which are competitive inhibitors of cAMP- and cGMP-dependent protein kinases. Next generation analogues exhibit a higher membrane permeability, increased resistance against degradation, and improved target specificity, or are caged or photoactivatable for fast and/or targeted cellular imaging. Novel specific nucleotide analogues activating or inhibiting cyclic nucleotide-dependent ion channels, EPAC/GEF proteins, and bacterial target molecules have been developed, opening new avenues for basic and applied research. This review provides an overview of the current state of the field, what can be expected in the future and some practical considerations for the use of cyclic nucleotide analogues in biological systems.

Keywords: 2′,3′-cGAMP; cAMP; cGMP; cyclic nucleotide analogues; cyclic nucleotide binding proteins.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Selected structures of cyclic nucleotides (1) cAMP (Adenosine-3′,5′-cyclic monophosphate syn-conformation), (2) cGMP (Guanosine-3′,5′-cyclic monophosphate), (3) Rp-cAMPS (Adenosine-3′,5′-cyclic monophosphorothioate, Rp-isomer; PKA antagonist), (4) Sp-cAMPS (Adenosine-3′,5′-cyclic monophosphorothioate, Sp-isomer; PKA agonist), (5) 8-pCPT-2′-O-Me-cAMP (8-(4-Chlorophenylthio)-2′-O-methyladenosine-3′,5′-cyclic monophosphate; EPAC activator), (6) cGAMP(2′-5′)/2′3′-cGAMP/2′,5′-3′,5′-cGAMP (Cyclic (guanosine-(2′ − 5′)-monophosphate-adenosine-3′ − 5′)- monophosphate)STING ligand), (7) 7-CH-cAMP/cTuMP (7-Deazaadenosine-3′,5′-cyclic monophosphate; HCN ligand), (8) 2′,3′-cAMP (Adenosine-2′,3′-cyclic monophosphate), (9) 7-PS(O)2E-8-T-cGMP (7-[2-(Phenylsulfonyl)ethyl]-8-thioguanosine-3′,5′-cyclic monophosphate; selective CNGolf/ret ligand), (10) 8-[Fluo]-cGMP/8-[Fluo]-AET-cGMP (8-(2-[Fluoresceinyl]aminoethylthio)guanosine-3′,5′-cyclic monophosphate PKG ligand, general cGMP-like binding fluorescence tool), (11) c-hexa-AMP; cyclic hexaadenylate (Cyclic hexa-adenosine monophosphate; CRISPR-CAS III ligand).

Similar articles

Cited by

References

    1. Sutherland E.W., Rall T.W. The properties of an adenine ribonucleotide produced with cellular particles, ATP, Mg++, and epinephrine or glucagon. J. Am. Chem. Soc. 1957;79:3608. doi: 10.1021/ja01570a087. - DOI
    1. Butcher R.W., Sutherland E.W. Adenosine 3′,5′-phosphate in biological materials. I. Purification and properties of cyclic 3′,5′-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3′,5′-phosphate in human urine. J. Biol. Chem. 1962;237:1244–1250. doi: 10.1016/S0021-9258(18)60316-3. - DOI - PubMed
    1. Krebs E.G., Fischer E.H. Phosphorylase activity of skeletal muscle extracts. J. Biol. Chem. 1955;216:113–120. doi: 10.1016/S0021-9258(19)52288-8. - DOI - PubMed
    1. Bartsch M., Zorn-Kruppa M., Kühl N., Genieser H.-G., Schwede F., Jastorff B. Bioactivatable, Membrane-Permeant Analogs of Cyclic Nucleotides as Biological Tools for Growth Control of C6 Glioma Cells. Biol. Chem. 2003;384:1321–1326. doi: 10.1515/BC.2003.148. - DOI - PubMed
    1. Schultz C., Vajanaphanich M., Genieser H.G., Jastorff B., Barrett K.E., Tsien R.Y. Membrane-permeant derivatives of cy-clic AMP optimized for high potency, prolonged activity, or rapid reversibility. Mol. Pharmacol. 1994;46:702–708. - PubMed

LinkOut - more resources